Wednesday, July 6, 2011

Biological Indicators usage inspection sterile drug manufacturing facility audit questionnaire

Questionnaire for biological Indicators usage, inspection in sterile drug manufacturing facility.

BIOLOGICAL INDICATOR USAGE

1. What type of indicator is used (e.g., inoculated carrier, inoculated product, inoculated simulated product, etc.).?
2. Is the source of the indicator commercial ( what is brand name and manufacturer ) or prepared in-house? (Identify supplier of organism, describe means of propagation and storage, and method of preparation. )
3. What organism is used (specify Genus, species)?
4. What is the challenge level of the biological indicator prior to exposure to sterilant?
5. Does firm verify viable spore count on each lot BIs?
6. Does the firm or the indicator labeling claim to meet USP performance criteria for steam or EtO biological indicators?
7. Does the firm perform USP testing on each lot of BIs received?
8. What is the approximate D-value of the biological indicator?
9. How many indicators are used per sterilizer load?
10. Describe the firm's procedure used to assay the indicators after exposure (i.e., USP, NASA, etc.). (Specify growth media used, optimal and actual incubation time and temperature. )
11. How are the indicators packaged for sterilization?
12. Are these biological indicators located in the most difficult.-tosterilize product sites (explain)?
13. Draw a diagram of the distribution of biological indicators in the loading pattern(s) for the selected drug product.
14. What is the elapsed time (hrs.) between removing indicators from the sterilizer and testing? Are there time limits established for this period? What happens if they are exceeded?
15. What is the average number of sterilizer loads processed per month?
16. How many sterilizer loads with positive indicator test results are there per year?
17. What is the disposition of lots with positive bioindicator tests results (release, relabel, resterilize, destroy, etc.)?
18. Describe biological indicator storage conditions:
a. Type of room, cabinet, etc. (if stored in freezer or refrigerator, state if frost-free)
b. Temperature
c. Relative humidity (if known)
d. Proximity of storage area to sterilizer(s)
19. If biological indicators are used to monitor EtO processes, also describe:
a. The storage history of the particular lot used in processing selected drug product (including dates of lot expiration lot received, lot sampled, etc.)
b. How long has this particular lot been held by the manufacturer?
c. If there a potential for the biological indicators to be exposed to EtO in the environment before use? (If yes, explain)
20. If the biological indicator testing is performed by a facility other than the primary manufacturer, what is the name and address of the facility.
21. Does the firm use chemical process monitor(s) to indicate cycle exposure or to measure one or more cycle parameters? (what is the type, brand name and how used.)
16. How many sterilizer loads with positive indicator test results are there per year?
17. What is the disposition of lots with positive bioindicator tests results (release, relabel, resterilize, destroy, etc.)?
18. Describe biological indicator storage conditions:
a. Type of room, cabinet, etc. (if stored in freezer or refrigerator, state if frost-free)
b. Temperature
c. Relative humidity (if known)
d. Proximity of storage area to sterilizer(s)
19. If biological indicators are used to monitor EtO processes, also describe:
a. The storage history of the particular lot used in processing selected drug product (including dates of lot expiration lot received, lot sampled, etc.)
b. How long has this particular lot been held by the manufacturer?
c. If there a potential for the biological indicators to be exposed to EtO in the environment before use? (If yes, explain)
20. If the biological indicator testing is performed by a facility other than the primary manufacturer, what is the name and address of the facility.
21. Does the firm use chemical process monitor(s) to indicate cycle exposure or to measure one or more cycle parameters? (what is type, brand name and how used.)

Also see
Aspects of Validation of Aseptic Process and Sterilisation , Sterilization of Equipment, Containers, and Closures

What is pharmaceutical product information manual (Pharmaceutical product dossier) for registration of  pharmaceutical product to foreign countries
--------------------------------------------------------------------------------------------------------

Process Validation guidelines Series 

Process Validation documentation.

Pharma process validation and concurrent release of PPQ batches

Process validation aspects of Analytical Methodology.

Process Validation Stage 3 The Continued Process Verification.

Process Validation : Process Qualification and Process Performance Qualification (PPQ)

Process Design and Process Validation Recommendations

Process validation and its regulatory, statutory requirements.

Process Validation and Drug Quality Approach to Process Validation.

General Considerations for Process Validation and Recommendations


Pharmaceutical Validation

Clean Room Classification

Quality by designe concept for pharmaceutical industry

Quality by designe concept in pharmaceutical industryan explanation

US FDA limits dosage of acetaminophen to 325 mg per unit dosage form,Requires boxed warning on lables

What is an Isolator in pharmaceutical manufacturing

What is a Laminar Air Flow Cabinet?

21 cfr part 11 FDA guidelines .

Media Fill Run To Ensure Sterility In Sterile Dosage Forms

What is HEPA filter?

Pharma sales jobs Find best Pharmaceutical sales job

No comments: